Verona pharma reports tqt study successfully demonstrated no clinically relevant effect on cardiac conduction

Study supports ongoing phase 3 program and planned nda submission study supports ongoing phase 3 program and planned nda submission

VRNA Ratings Summary

VRNA Quant Ranking